Calling Students + Recent Grads • $300,000 in PrizesHow can your new technology solution or service help benefit the economy, society or the environment?
CLAREMONT, CA (PRWEB) MARCH 13, 2017
Six Winners Out of 175 Applicants Awarded Prizes to Develop Clean Energy Technologies, Grow their Businesses, Create Jobs, and Advance Clean Energy Economy
Republished from The Children's Prize Foundation Newsletter
Oncolinx, in conjunction with the National Cancer Institute is developing the next generation of targeted cancer therapies: antibody-drug conjugates (ADCs). Oncolinx ADCs carry a patented, immune-activating drug payload called the Azonafide directly, and exclusively, to cancer cells, and not healthy cells, thereby avoiding many of the adverse side-effects of chemotherapy.